Your browser doesn't support javascript.
loading
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora, S; Andreassen, A K; Andersson, B; Gustafsson, F; Eiskjaer, H; Bøtker, H E; Rådegran, G; Gude, E; Ioanes, D; Solbu, D; Sigurdardottir, V; Dellgren, G; Erikstad, I; Solberg, O G; Ueland, T; Aukrust, P; Gullestad, L.
Afiliação
  • Arora S; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Andreassen AK; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Andersson B; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Gustafsson F; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.
  • Eiskjaer H; Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
  • Bøtker HE; Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
  • Rådegran G; The Clinic for Heart Failure and Valvular Disease, Skåne University Hospital and Lund University, Lund, Sweden.
  • Gude E; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Ioanes D; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Solbu D; Novartis Norge AS, Oslo, Norway.
  • Sigurdardottir V; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Dellgren G; Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Erikstad I; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Solberg OG; Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Ueland T; Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Aukrust P; K.G. Jebsen Inflammatory Research Center, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Gullestad L; Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Am J Transplant ; 15(7): 1967-75, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25783974

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Transplante de Coração / Inibidores de Calcineurina / Transplantados / Everolimo / Rejeição de Enxerto / Cardiopatias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Vasculares / Transplante de Coração / Inibidores de Calcineurina / Transplantados / Everolimo / Rejeição de Enxerto / Cardiopatias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Noruega